[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Europe Cholera Vaccine Market Research Report Forecast 2017-2021

June 2017 | 127 pages | ID: E9610CA7D83EN
S&P Consulting

US$ 3,040.00 US$ 3,800.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Europe Cholera Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Cholera Vaccine industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Cholera Vaccine market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of
  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs
Europe Cholera Vaccine Market Analysis by Countries:

Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:

BiondVax Pharmaceuticals
Bharat Biotech International Limited
GlaxoSmithKline
Hualan Biological Engineering
Janssen Pharmaceuticals
MedImmune
Merck
Pfizer
Sanofi Pasteur SA

Europe Cholera Vaccine Market Analysis by Product :
  • Type 1
  • Type 2
  • Type 3
Europe Cholera Vaccine Market Analysis by Application:
  • Application 1
  • Application 2
  • Application 3
Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
1 CHOLERA VACCINE MARKET OVERVIEW

1.1 Product Overview and Scope of Cholera Vaccine
1.2 Classification of Cholera Vaccine
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Cholera Vaccine
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Cholera Vaccine Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Cholera Vaccine (2012-2021)
  1.5.1 Europe Cholera Vaccine Sales and Growth Rate (2012-2021)
  1.5.2 Europe Cholera Vaccine Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON CHOLERA VACCINE INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 CHOLERA VACCINE MANUFACTURING COST ANALYSIS

3.1 Cholera Vaccine Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Cholera Vaccine

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Cholera Vaccine Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Cholera Vaccine Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE CHOLERA VACCINE MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Cholera Vaccine Market Competition by Manufacturers
  5.1.1 Europe Cholera Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Cholera Vaccine Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Cholera Vaccine (Volume and Value) by Type
  5.2.1 Europe Cholera Vaccine Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Cholera Vaccine Revenue and Market Share by Type (2012-2017)
5.3 Europe Cholera Vaccine (Volume and Value) by Countries
  5.3.1 Europe Cholera Vaccine Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Cholera Vaccine Revenue and Market Share by Countries (2012-2017)
5.4 Europe Cholera Vaccine (Volume) by Application

6 GERMANY CHOLERA VACCINE (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Cholera Vaccine Sales and Value (2012-2017)
  6.1.1 Germany Cholera Vaccine Sales and Growth Rate (2012-2017)
  6.1.2 Germany Cholera Vaccine Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Cholera Vaccine Sales Price Trend (2012-2017)
6.2 Germany Cholera Vaccine Sales and Market Share by Manufacturers
6.3 Germany Cholera Vaccine Sales and Market Share by Type
6.4 Germany Cholera Vaccine Sales and Market Share by Application

7 FRANCE CHOLERA VACCINE (VOLUME, VALUE AND SALES PRICE)

7.1 France Cholera Vaccine Sales and Value (2012-2017)
  7.1.1 France Cholera Vaccine Sales and Growth Rate (2012-2017)
  7.1.2 France Cholera Vaccine Revenue and Growth Rate (2012-2017)
  7.1.3 France Cholera Vaccine Sales Price Trend (2012-2017)
7.2 France Cholera Vaccine Sales and Market Share by Manufacturers
7.3 France Cholera Vaccine Sales and Market Share by Type
7.4 France Cholera Vaccine Sales and Market Share by Application

8 UK CHOLERA VACCINE (VOLUME, VALUE AND SALES PRICE)

8.1 UK Cholera Vaccine Sales and Value (2012-2017)
  8.1.1 UK Cholera Vaccine Sales and Growth Rate (2012-2017)
  8.1.2 UK Cholera Vaccine Revenue and Growth Rate (2012-2017)
  8.1.3 UK Cholera Vaccine Sales Price Trend (2012-2017)
8.2 UK Cholera Vaccine Sales and Market Share by Manufacturers
8.3 UK Cholera Vaccine Sales and Market Share by Type
8.4 UK Cholera Vaccine Sales and Market Share by Application

9 RUSSIA CHOLERA VACCINE (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Cholera Vaccine Sales and Value (2012-2017)
  9.1.1 Russia Cholera Vaccine Sales and Growth Rate (2012-2017)
  9.1.2 Russia Cholera Vaccine Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Cholera Vaccine Sales Price Trend (2012-2017)
9.2 Russia Cholera Vaccine Sales and Market Share by Manufacturers
9.3 Russia Cholera Vaccine Sales and Market Share by Type
9.4 Russia Cholera Vaccine Sales and Market Share by Application

10 ITALY CHOLERA VACCINE (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Cholera Vaccine Sales and Value (2012-2017)
  10.1.1 Italy Cholera Vaccine Sales and Growth Rate (2012-2017)
  10.1.2 Italy Cholera Vaccine Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Cholera Vaccine Sales Price Trend (2012-2017)
10.2 Italy Cholera Vaccine Sales and Market Share by Manufacturers
10.3 Italy Cholera Vaccine Sales and Market Share by Type
10.4 Italy Cholera Vaccine Sales and Market Share by Application

11 SPAIN CHOLERA VACCINE (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Cholera Vaccine Sales and Value (2012-2017)
  11.1.1 Spain Cholera Vaccine Sales and Growth Rate (2012-2017)
  11.1.2 Spain Cholera Vaccine Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Cholera Vaccine Sales Price Trend (2012-2017)
11.2 Spain Cholera Vaccine Sales and Market Share by Manufacturers
11.3 Spain Cholera Vaccine Sales and Market Share by Type
11.4 Spain Cholera Vaccine Sales and Market Share by Application

12 BENELUX CHOLERA VACCINE (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Cholera Vaccine Sales and Value (2012-2017)
  12.1.1 Benelux Cholera Vaccine Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Cholera Vaccine Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Cholera Vaccine Sales Price Trend (2012-2017)
12.2 Benelux Cholera Vaccine Sales and Market Share by Manufacturers
12.3 Benelux Cholera Vaccine Sales and Market Share by Type
12.4 Benelux Cholera Vaccine Sales and Market Share by Application

13 EUROPE CHOLERA VACCINE MANUFACTURERS ANALYSIS

13.1 BiondVax Pharmaceuticals
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Bharat Biotech International Limited
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 GlaxoSmithKline
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Hualan Biological Engineering
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Janssen Pharmaceuticals
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 MedImmune
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 Merck
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Pfizer
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Sanofi Pasteur SA
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE CHOLERA VACCINE MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Cholera Vaccine Market Forecast by Type (2017-2021)
15.9 Europe Cholera Vaccine Market Forecast by Application (2017-2021)

16 APPENDIX

LIST OF TABLES AND FIGURES

Figure Picture of Cholera Vaccine
Table Classification of Cholera Vaccine
Figure Europe Sales Market Share of Cholera Vaccine by Type in 2015
Table Application of Cholera Vaccine
Figure Europe Sales Market Share of Cholera Vaccine by Application in 2015
Figure Germany Cholera Vaccine Revenue and Growth Rate (2012-2021)
Figure France Cholera Vaccine Revenue and Growth Rate (2012-2021)
Figure UK Cholera Vaccine Revenue and Growth Rate (2012-2021)
Figure Russia Cholera Vaccine Revenue and Growth Rate (2012-2021)
Figure Italy Cholera Vaccine Revenue and Growth Rate (2012-2021)
Figure Spain Cholera Vaccine Revenue and Growth Rate (2012-2021)
Figure Benelux Cholera Vaccine Revenue and Growth Rate (2012-2021)
Figure Europe Cholera Vaccine Sales and Growth Rate (2012-2021)
Figure Europe Cholera Vaccine Revenue and Growth Rate (2012-2021)
Table Europe Cholera Vaccine Sales of Key Manufacturers (2015 and 2016)
Table Europe Cholera Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Cholera Vaccine Sales Share by Manufacturers
Figure 2016 Cholera Vaccine Sales Share by Manufacturers
Table Europe Cholera Vaccine Revenue by Manufacturers (2015 and 2016)
Table Europe Cholera Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Cholera Vaccine Revenue Share by Manufacturers
Table 2016 Europe Cholera Vaccine Revenue Share by Manufacturers
Table Europe Cholera Vaccine Sales and Market Share by Type (2012-2017)
Table Europe Cholera Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Cholera Vaccine by Type (2012-2017)
Figure Europe Cholera Vaccine Sales Growth Rate by Type (2012-2017)
Table Europe Cholera Vaccine Revenue and Market Share by Type (2012-2017)
Table Europe Cholera Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cholera Vaccine by Type (2012-2017)
Figure Europe Cholera Vaccine Revenue Growth Rate by Type (2012-2017)
Table Europe Cholera Vaccine Sales and Market Share by Countries (2012-2017)
Table Europe Cholera Vaccine Sales Share by Countries (2012-2017)
Figure Sales Market Share of Cholera Vaccine by Countries (2012-2017)
Table Europe Cholera Vaccine Revenue and Market Share by Countries (2012-2017)
Table Europe Cholera Vaccine Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Cholera Vaccine by Countries (2012-2017)
Table Europe Cholera Vaccine Sales and Market Share by Application (2012-2017)
Table Europe Cholera Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Cholera Vaccine by Application (2012-2017)
Figure Germany Cholera Vaccine Sales and Growth Rate (2012-2017)
Figure Germany Cholera Vaccine Revenue and Growth Rate (2012-2017)
Figure Germany Cholera Vaccine Sales Price Trend (2012-2017)
Table Germany Cholera Vaccine Sales by Manufacturers (2015 and 2016)
Table Germany Cholera Vaccine Market Share by Manufacturers (2015 and 2016)
Table Germany Cholera Vaccine Sales by Type (2015 and 2016)
Table Germany Cholera Vaccine Market Share by Type (2015 and 2016)
Table Germany Cholera Vaccine Sales by Application (2015 and 2016)
Table Germany Cholera Vaccine Market Share by Application (2015 and 2016)
Figure France Cholera Vaccine Sales and Growth Rate (2012-2017)
Figure France Cholera Vaccine Revenue and Growth Rate (2012-2017)
Figure France Cholera Vaccine Sales Price Trend (2012-2017)
Table France Cholera Vaccine Sales by Manufacturers (2015 and 2016)
Table France Cholera Vaccine Market Share by Manufacturers (2015 and 2016)
Table France Cholera Vaccine Sales by Type (2015 and 2016)
Table France Cholera Vaccine Market Share by Type (2015 and 2016)
Table France Cholera Vaccine Sales by Application (2015 and 2016)
Table France Cholera Vaccine Market Share by Application (2015 and 2016)
Figure UK Cholera Vaccine Sales and Growth Rate (2012-2017)
Figure UK Cholera Vaccine Revenue and Growth Rate (2012-2017)
Figure UK Cholera Vaccine Sales Price Trend (2012-2017)
Table UK Cholera Vaccine Sales by Manufacturers (2015 and 2016)
Table UK Cholera Vaccine Market Share by Manufacturers (2015 and 2016)
Table UK Cholera Vaccine Sales by Type (2015 and 2016)
Table UK Cholera Vaccine Market Share by Type (2015 and 2016)
Table UK Cholera Vaccine Sales by Application (2015 and 2016)
Table UK Cholera Vaccine Market Share by Application (2015 and 2016)
Figure Russia Cholera Vaccine Sales and Growth Rate (2012-2017)
Figure Russia Cholera Vaccine Revenue and Growth Rate (2012-2017)
Figure Russia Cholera Vaccine Sales Price Trend (2012-2017)
Table Russia Cholera Vaccine Sales by Manufacturers (2015 and 2016)
Table Russia Cholera Vaccine Market Share by Manufacturers (2015 and 2016)
Table Russia Cholera Vaccine Sales by Type (2015 and 2016)
Table Russia Cholera Vaccine Market Share by Type (2015 and 2016)
Table Russia Cholera Vaccine Sales by Application (2015 and 2016)
Table Russia Cholera Vaccine Market Share by Application (2015 and 2016)
Figure Italy Cholera Vaccine Sales and Growth Rate (2012-2017)
Figure Italy Cholera Vaccine Revenue and Growth Rate (2012-2017)
Figure Italy Cholera Vaccine Sales Price Trend (2012-2017)
Table Italy Cholera Vaccine Sales by Manufacturers (2015 and 2016)
Table Italy Cholera Vaccine Market Share by Manufacturers (2015 and 2016)
Table Italy Cholera Vaccine Sales by Type (2015 and 2016)
Table Italy Cholera Vaccine Market Share by Type (2015 and 2016)
Table Italy Cholera Vaccine Sales by Application (2015 and 2016)
Table Italy Cholera Vaccine Market Share by Application (2015 and 2016)
Figure Spain Cholera Vaccine Sales and Growth Rate (2012-2017)
Figure Spain Cholera Vaccine Revenue and Growth Rate (2012-2017)
Figure Spain Cholera Vaccine Sales Price Trend (2012-2017)
Table Spain Cholera Vaccine Sales by Manufacturers (2015 and 2016)
Table Spain Cholera Vaccine Market Share by Manufacturers (2015 and 2016)
Table Spain Cholera Vaccine Sales by Type (2015 and 2016)
Table Spain Cholera Vaccine Market Share by Type (2015 and 2016)
Table Spain Cholera Vaccine Sales by Application (2015 and 2016)
Table Spain Cholera Vaccine Market Share by Application (2015 and 2016)
Figure Benelux Cholera Vaccine Sales and Growth Rate (2012-2017)
Figure Benelux Cholera Vaccine Revenue and Growth Rate (2012-2017)
Figure Benelux Cholera Vaccine Sales Price Trend (2012-2017)
Table Benelux Cholera Vaccine Sales by Manufacturers (2015 and 2016)
Table Benelux Cholera Vaccine Market Share by Manufacturers (2015 and 2016)
Table Benelux Cholera Vaccine Sales by Type (2015 and 2016)
Table Benelux Cholera Vaccine Market Share by Type (2015 and 2016)
Table Benelux Cholera Vaccine Sales by Application (2015 and 2016)
Table Benelux Cholera Vaccine Market Share by Application (2015 and 2016)
Table BiondVax Pharmaceuticals Basic Information List
Table BiondVax Pharmaceuticals Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure BiondVax Pharmaceuticals Cholera Vaccine Sales Market Share (2012-2017)
Table Bharat Biotech International Limited Basic Information List
Table Bharat Biotech International Limited Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Bharat Biotech International Limited Cholera Vaccine Sales Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Cholera Vaccine Sales Market Share (2012-2017)
Table Hualan Biological Engineering Basic Information List
Table Hualan Biological Engineering Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Hualan Biological Engineering Cholera Vaccine Sales Market Share (2012-2017)
Table Janssen Pharmaceuticals Basic Information List
Table Janssen Pharmaceuticals Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Janssen Pharmaceuticals Cholera Vaccine Sales Market Share (2012-2017)
Table MedImmune Basic Information List
Table MedImmune Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table MedImmune Cholera Vaccine Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Cholera Vaccine Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Cholera Vaccine Sales Market Share (2012-2017)
Table Sanofi Pasteur SA Basic Information List
Table Sanofi Pasteur SA Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Pasteur SA Cholera Vaccine Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cholera Vaccine
Figure Manufacturing Process Analysis of Cholera Vaccine
Figure Cholera Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Cholera Vaccine Major Manufacturers in 2015
Table Major Buyers of Cholera Vaccine
Table Distributors/Traders List
Figure Germany Cholera Vaccine Sales and Growth Rate Forecast (2017-2021)
Figure Germany Cholera Vaccine Revenue and Growth Rate Forecast (2017-2021)
Figure France Cholera Vaccine Sales and Growth Rate Forecast (2017-2021)
Figure France Cholera Vaccine Revenue and Growth Rate Forecast (2017-2021)
Figure UK Cholera Vaccine Sales and Growth Rate Forecast (2017-2021)
Figure UK Cholera Vaccine Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Cholera Vaccine Sales and Growth Rate Forecast (2017-2021)
Figure Russia Cholera Vaccine Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Cholera Vaccine Sales and Growth Rate Forecast (2017-2021)
Figure Italy Cholera Vaccine Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Cholera Vaccine Sales and Growth Rate Forecast (2017-2021)
Figure Spain Cholera Vaccine Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Cholera Vaccine Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Cholera Vaccine Revenue and Growth Rate Forecast (2017-2021)
Table Europe Cholera Vaccine Sales Forecast by Type (2017-2021)
Table Europe Cholera Vaccine Sales Forecast by Application (2017-2021)


More Publications